Abstract:Background: MiR-196a is particularly noticeable in the development of liver cancer. However, the rapid degradation by ribonuclease (RNase) imposes a limit on the miRNA gene therapy applications.Aims: To design a novel gene-targeting nano system for liver cancer treatment.Study Design: Cell culture study and animal experimentation.Methods: Deacetylated (DEAC)-poly-N-acetylglucosamine (PNAG)-folic acid (FA) was prepared via ethyl (dimethylaminopropyl) carbodiimide/N-hydroxysuccinimide reaction, and miR-196a inhibitor (miR-196a I)/DEAC-PNAG-FA was prepared through self-assembly. The characterization and nucleic acid protection of the self-assembly system were also determined. The biological function and related mechanism of the prepared system were studied at cellular and molecular levels. Mice were established as a xenotransplantation model to evaluate the anticancer capacity of miR-196a I/DEAC-PNAG-FA in vivo.Results: The morphology of miR-196a I/DEAC-PNAG-FA was uniform, and its particle size was approximately 70-100 nm. A nanocarrier with an N/P ratio of 200:1 can maximize the nucleic acid carrying capacity of the self-assembly system. The nanosystem can protect miRNA from RNase degradation and could be internalized rapidly within 4 h. The self-assembly system significantly enhanced the apoptosis-inducing effect of miR-196a I on HepG2 cells (P = 0.003). Molecular biological analyses confirmed that the apoptosis-inducing effect of the nanosystem was due to the inhibition of miR-196a gene expression in HepG2 cells, which upregulate the expression of pro-apoptotic proteins FOXO1 (P < 0.001), Bax (P < 0.001), Ki67 (P < 0.001), and proliferating cell nuclear antigen (P < 0.001), and inhibit the expression of apoptosis inhibitory protein Bcl-2 (P < 0.001). Moreover, compared with free miR-196a inhibitor or miR-196a I/DEAC-PNAG, miR-196a I/DEAC-PNAG-FA can more effectively inhibit tumor growth in vivo (P = 0.026).Conclusion: The newly prepared self-assembly targeting system can effectively induce apoptosis and abrogate tumor growth, which may open a new approach for liver cancer treatment.

Protamine Sulfate-Nanodiamond Hybrid Nanoparticles As A Vector for Mir-203 Restoration in Esophageal Carcinoma Cells

Cell‐Penetrating Poly(disulfide) Assisted Intracellular Delivery of Mesoporous Silica Nanoparticles for Inhibition of Mir‐21 Function and Detection of Subsequent Therapeutic Effects

Tumor specific delivery with redox-triggered mesoporous silica nanoparticles inducing neovascularization suppression and vascular normalization

Near‐Infrared Induced Mir‐34a Delivery from Nanoparticles in Esophageal Cancer Treatment

Targeted Delivery of Anti-Mir-155 by Functionalized Mesoporous Silica Nanoparticles for Colorectal Cancer Therapy

Integrated Combination Treatment Using a "smart" Chemotherapy and MicroRNA Delivery System Improves Outcomes in an Orthotopic Colorectal Cancer Model

Endosomolytic and Tumor-Penetrating Mesoporous Silica Nanoparticles for siRNA/miRNA Combination Cancer Therapy.

Sequential Co-Delivery of Mir-21 Inhibitor Followed by Burst Release Doxorubicin Using NIR-responsive Hollow Gold Nanoparticle to Enhance Anticancer Efficacy

GLUT1-mediated Effective Anti-Mirna21 Pompon for Cancer Therapy

Two-Step Assembling of Near-Infrared "OFF-ON" Fluorescent Nanohybrids for Synchronous Tumor Imaging and MicroRNA Modulation-Based Therapy.

Targeted Delivery of Antisense Inhibitor of Mirna for Antiangiogenesis Therapy Using Crgd-Functionalized Nanoparticles

Multipotent Mirna Sponge-Loaded Magnetic Nanodroplets with Ultrasound/Magnet-Assisted Delivery for Hepatocellular Carcinoma Therapy

Preparation and Evaluation of Upconversion Nanoparticles Based miRNA Delivery Carrier in Colon Cancer Mice Model

Co-delivery of CPP decorated doxorubicin and CPP decorated siRNA by NGR-modified nanobubbles for improving anticancer therapy

Polymeric Hybrid Nanomicelles for Cancer Theranostics: an Efficient and Precise Anticancer Strategy for the Codelivery of Doxorubicin/miR-34a and Magnetic Resonance Imaging.

A Cancer Cell Membrane Coated, Doxorubicin and Microrna Co-Encapsulated Nanoplatform for Colorectal Cancer Theranostics

Increased Mir-203-3p and Reduced Mir-21-5p Synergistically Inhibit Proliferation, Migration, and Invasion in Esophageal Cancer Cells

Imaging Dendrimer-Grafted Graphene Oxide Mediated Anti-Mir-21 Delivery With An Activatable Luciferase Reporter

Deacetylated-poly-N-acetylglucosamine-folic Acid as a Nanocarrier for Delivering miR-196a Inhibitor to Anticancer Activity

Targeted delivery of miR-200c/DOC to inhibit cancer stem cells and cancer cells by the gelatinases-stimuli nanoparticles.

A Tumor Microenvironment-Stimuli Responsive Nano-Prodrug for Overcoming Gemcitabine Chemoresistance by Co-Delivered Mirna-21 Modulator